Molecular Characterization of WCK 5222 (Cefepime/Zidebactam)-Resistant Mutants Developed from a Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate

Authors:

Abstract
Antibiotic resistance imposes a severe threat on human health. WCK 5222 is a β-lactam/β-lactamase inhibitor combination that is composed of cefepime and zidebactam.
Funding Information
  • National Science Foundation of China (31970680)
  • National Science Foundation of China (31970179)
  • National Science Foundation of China (31870130)
  • MOST | National Key Research and Development Program of China (2021YFE0101700)
  • Tianjin Municipal Science and Technology Committee (19JCYBJC24700)

This publication has 31 references indexed in Scilit: